How to build anti-PD1 agonist antibodies

被引：0
|
作者：
Flemming, Alexandra
机构：
[1] Nature Reviews Immunology,
来源：
NATURE REVIEWS IMMUNOLOGY | 2023年 / 23卷 / 03期
关键词：
D O I：
10.1038/s41577-023-00844-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A paper in Science Immunology describes the crucial features of agonist antibodies to the checkpoint molecule PD1.
引用
收藏
页码：139 / 139
页数：1
相关论文
共 50 条
  • [31] Auranofin enhances the efficacy of anti-PD1 immunotherapy
    Zhao, Zichen
    Hu, Shichuan
    Zhang, Yan
    CANCER RESEARCH, 2024, 84 (06)
  • [32] Bullous pemphigoid under anti-PD1 therapy
    Wirbel, C.
    Milley, S.
    Balme, B.
    Dalle, S.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2020, 147 (11): : 795 - 797
  • [33] Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies
    Sanlorenzo, Martina
    Vujic, Igor
    Floris, Arianna
    Novelli, Mauro
    Donini, Chiara
    Gammaitoni, Loretta
    Giraudo, Lidia
    Macagno, Marco
    Quaglino, Pietro
    Fierro, Maria Teresa
    Giordano, Silvia
    Carnevale-Schianca, Fabrizio
    Aglietta, Massimo
    Sangiolo, Dario
    CANCER RESEARCH, 2017, 77
  • [34] Anti-PD1 in the wonder-gut-land
    Vetizou, Marie
    Trinchieri, Giorgio
    CELL RESEARCH, 2018, 28 (03) : 263 - 264
  • [35] Interrogating anti-PD1 immunotherapy resistance mechanisms
    Uppaluri, Ravindra
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 21 - 21
  • [36] Thyroid toxicity and anti-thyroid antibodies as predictive markers for patients treated with anti-PD1 checkpoint therapy
    Meer, W. V. D.
    Basak, E. A.
    Hurkmans, D. P.
    Schreurs, M. W. J.
    Oomen-de Hoop, E.
    Van der Veldt, A. A. M.
    Bins, S.
    Joosse, A.
    Koolen, S. L.
    Debets, R.
    Peeters, R. P.
    Aerts, J. G.
    Mathijssen, R. H.
    Medici, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] Evaluation of niraparib in combination with anti-PD1/anti-PD-L1 in preclinical models
    Wang, Sarah
    Sun, Kaiming
    Xiao, Yonghong
    Feng, Bin
    Mikule, Keith
    Ramaswamy, Sridhar
    Hanke, Jeffrey
    Wang, Jing
    CANCER RESEARCH, 2018, 78 (13)
  • [38] Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies
    Puccini, Alberto
    Battaglin, Francesca
    Iaia, Maria Laura
    Lenz, Heinz-Josef
    Salem, Mohamed E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [39] Anti-PD1 role in treatment of cutaneous melanoma
    Mateus, Christine
    Libenciuc, Cristina
    Robert, Caroline
    BULLETIN DU CANCER, 2016, 103 (06) : S4 - S11
  • [40] Anti-PD1 in the wonder-gut-land
    Marie Vetizou
    Giorgio Trinchieri
    Cell Research, 2018, 28 : 263 - 264
12345